Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ireland

 

Ireland’s ‘Fair Deal Scheme’ for nursing homes under fire

As an Irish nursing home is pulls one of its homes out of the public funding scheme citing “extreme financial pressure”, and elements in the government appear increasingly hostile to for-profits in the sector, HBI speaks to a market expert and asks if this is a blip, or a trend.
May 12, 2023

Medica results show familiar state of UK healthcare services

Medica, which provides teleradiology services to the UK NHS, operates in Ireland, and has a presence in the US, has released its latest financial results. The company is continuing to grow, but feeling the pinch from inflationary pressures.
April 14, 2023

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023

EU approves new digi-physical primary care service in Ireland

The EU has given the green light to a joint venture between Centric Health, Ireland’s only major private primary care chain, and Irish Life Health, one of Ireland’s four private health insurers. The joint venture will provide a new digi-physical primary care service to Irish Life Health customers. 
January 19, 2023

Opportunities in Irish dentistry

The dental market in Ireland may not be the largest in Europe, but it is largely (80% plus) a private market with very little consolidation. So why haven't we seen more consolidation? HBI speaks to a market expert to find out more.
October 13, 2022

Four Seasons seller happy to split group for sale

Potential buyers of Four Seasons Health Care Group’s (FSHC) 110 homes must place their bids before the end of September, insists Christie & Co, the business broker in charge of the sale.
August 16, 2022

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
April 28, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022

Lim and others eye up IVIRMA

Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.
March 10, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us